The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Westlake Chemical's revenues will drop -3.2% and EPS will expand 202.5%.
The average estimate for revenue is $831.3 million. On the bottom line, the average EPS estimate is $1.21.
Last quarter, Westlake Chemical reported revenue of $821.2 million. GAAP reported sales were 15% lower than the prior-year quarter's $968.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.37. GAAP EPS of $1.30 for Q3 were 29% higher than the prior-year quarter's $1.01 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 21.0%, 580 basis points better than the prior-year quarter. Operating margin was 17.4%, 530 basis points better than the prior-year quarter. Net margin was 10.6%, 360 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $3.59 billion. The average EPS estimate is $5.46.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 95 members out of 107 rating the stock outperform, and 12 members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Westlake Chemical a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Westlake Chemical is hold, with an average price target of $67.43.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Westlake Chemical to My Watchlist.